Nine Point Two Capital LLC Alector, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Alector, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 18,542 shares of ALEC stock, worth $22,992. This represents 0.06% of its overall portfolio holdings.
Number of Shares
18,542
Previous 18,542
-0.0%
Holding current value
$22,992
Previous $120,000
22.5%
% of portfolio
0.06%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding ALEC
# of Institutions
159Shares Held
58MCall Options Held
614KPut Options Held
223K-
Black Rock Inc. New York, NY9.1MShares$11.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.99MShares$8.67 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.03MShares$7.48 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$2.94 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$2.71 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $102M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...